AstraZeneca Halts £200m Cambridge Expansion Amid Growing Pressure on UK Pharma Sector
AstraZeneca has paused its planned £200 million investment to expand its Cambridge research site, dealing another setback to the UK’s pharmaceutical industry just days after US rival Merck scrapped a major London project. The Cambridge expansion, announced by the former government in March 2024, was expected to create 1,000 jobs and significantly boost the UK’s…